Action Alert
Pfizer/BioNTech has asked the Federal Food and Drug Administration (FDA) to expand the Emergency Use Authorization (EUA) of their COVID-19 vaccine for young children ages 6 months through 4 years. The FDA’s Vaccines and Related Biological Products Advisory Committee will meet on February 15th to evaluate their EUA application. If approved, the vaccine is likely […]